Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Marc Huntoon

Pain Medicine Nashville, TN Medical Doctor

NPI 1306816707 CMS profile 13309

3601 Tvc, Nashville, TN 37232

Open in the dashboard

General payments

$36,876

74 records reported · program years 2019–2023

Research payments

$7,560

Paid to them · 12 records reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Marc Huntoon of Nashville, TN is reported in the CMS Open Payments database as having received $36,876 across 74 general payments and $7,560 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $127 4
2022 General $10,258 25
2022 Research $3,160 4
2021 General $12,981 17
2021 Research $1,800 3
2020 General $12,366 10
2020 Research $800 1
2019 General $1,145 18
2019 Research $1,800 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marc Huntoon
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Marc Huntoon were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Marc Huntoon Pain Medicine median Middle half National median
2019 $1,145 $498 $126–$1,682 $163
2020 $12,366 $284 $80–$910 $114
2021 $12,981 $399 $112–$1,219 $132
2022 $10,258 $455 $137–$1,484 $149
2023 $127 $484 $128–$1,495 $160
2024 $0 $498 $131–$1,540 $164
2025 $0 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. SPR Therapeutics, Inc $34,586 37 payments
  2. Medtronic USA, Inc. $1,273 19 payments
  3. Nevro Corp. $436 8 payments
  4. Medtronic, Inc. $259 4 payments
  5. Boston Scientific Corporation $172 2 payments
  6. Vertos Medical, Inc. $103 1 payment
  7. Avanos Medical $18 1 payment
  8. Teva Pharmaceuticals USA, Inc. $17 1 payment
  9. Abbott Laboratories $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $19,800 2 payments
  2. Food and Beverage $15,899 65 payments
  3. Travel and Lodging $1,176 7 payments
Products named General payments · program years 2019–2023
  1. SPRINT PNS System $34,586 37 payments
  2. RESTORE $529 7 payments
  3. Omnia $403 7 payments
  4. INTELLIS $367 4 payments
  5. INTELLIS ADAPTIVESTIM $238 3 payments
  6. SYNCHROMED $212 4 payments
  7. AUTOFILL $108 1 payment
  8. mild Device Kit $103 1 payment
  9. GENERAL PAIN MANAGEMENT $93 1 payment
  10. GENERAL - PAIN MANAGEMENT $79 1 payment
  11. Other $158 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Saluda Medical Americas, Inc. $7,560 12 payments

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record